Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

VRDN — Viridian Therapeutics, Inc. Dilution Risk Tracker

Track VRDN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VRDN — Get alerts when the score changes →

As of October 13, 2026, Viridian Therapeutics, Inc. (VRDN) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Viridian Therapeutics, Inc. has a market capitalization of $2.05B, 113.29M shares outstanding, 227 institutional holders tracked. Stored dilution-related fields include 29.4K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
65
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄 Convertible Debt
35

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 12%
💰 Capital Raise model 15%
• Under 12 months cash (6mo)
🔁 Convertible Conversion model 15%
• Convertible debt present: 11.7% potential dilution
🔔 Track VRDN — Get forecast alerts →

Market Data

Market Cap$2.05B
Shares Outstanding113.29M
Float103.02M
Cash$169.43M
Debt$29.32M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding113.29MVerified float table or market cache
Public Float103.02MVerified float table or market cache
Market Cap$2.05BMarket data cache
Cash Runway6.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants29.4KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 16.6% shares (2026Q1 vs prior)
227 institutional holders · 126.67M shares
#1 FMR LLC 15.38M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 8.33M shares
#3 BlackRock, Inc. 7.83M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest17.97M
Days to Cover8.9
% of Float17.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-08-06
xbrl XBRL WARRANT 2026-02-26
4 INSIDER TRANSACTION 2026-07-02
4 INSIDER TRANSACTION 2026-07-02
4 INSIDER TRANSACTION 2026-07-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual VRDN Dilution Snapshot

Viridian Therapeutics, Inc. (VRDN) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

VRDN's DilutionScore is currently 50/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 52/100 (High risk).

Period Score Risk Level Duration
Sep 29 – Oct 13, 202650/100MEDIUM15 days
Aug 22 – Sep 28, 202652/100HIGH38 days
Aug 14 – Aug 21, 202654/100HIGH7 days
Jul 16 – Aug 13, 202652/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

VRDN shares outstanding have increased 8.0% from 102.21M (Mar 2026) to 110.43M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 2026110.43M103.02M▲ 5.55%
May 12, 2026103.07M97.60M▼ 5.26%
May 06, 2026103.07M103.02M▲ 0.85%
Mar 26, 2026102.21M102.15M▼ 0.03%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track VRDN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment VRDN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking VRDN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VRDN
VRDN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.